Uterine receptivity is a transient state in which the uterus can accept an embryo to implant into the uterine wall. It is controlled by the ovarian hormones progesterone (P4) and estrogen (E2). P4 and E2 exert their uterine effects mainly through their respective receptors, PR and ER. Bisphenol-A (BPA) is an endocrine disruptor that has been widely used in polycarbonate plastics and epoxy resins. It has been demonstrated that BPA has adverse effects on uterine development and can alter uterine expression of PR and ER. In addition, it has been reported that BPA treatment at ~400 mg/kg/day in early pregnancy is detrimental to embryo implantation. However, it is unknown whether the adverse effect is on the embryo or the uterus or both during embryo implantation. To investigate the potential effect of BPA on uterine receptivity, wild type C57B6/129 mixed background young adult females (4-6 each group) were mated with untreated wild type stud males. The timed pregnant mice were treated with 0, 40, 100, and 400 mg/kg/day BPA (dissolved in sesame oil) daily via subcutaneously injection from embryonic day 0.5 to 3.5. Implantation sites were visualized with Evans blue dye injection at day 4.5 (mating night as day 0, implantation normally initiates ~ day 4.0 in mice). No implantation sites were detected in both100 and 400 mg/kg/day BPA treated groups. No embryos were flushed from these uteri either, indicating that BPA at these high doses are toxic to the early stage embryos. Reduced number of implantation sites were detected in the 40 mg/kg/day BPA treated group. However, the appearance of the blue bands (implantation sites) was not as sharp as those seen in the uteri of the control group. Immunohistochemistry of PR indicated that there was no decidual zone at the implantation sites in the 40 mg/kg/day BPA treated group, and PR was highly expressed in the luminal epithelium, suggesting that implantation was abnormal in this group. PR expression disappeared from the luminal epithelium but was strong in the primary decidal zone in the implantation sites from the control group. PR expression in day 4.5 uteri from both100 and 400 mg/kg/day BPA treated groups was also dysregulated. To further define the effect of BPA on uterine receptivity at these high doses, we will transfer embryos from untreated females into BPA-treated pseudo-pregnant uterus. Our results demonstrate that high doses of BPA are detrimental to early stage embryos and their effect on uterine receptivity awaits further clarification. (Supported by startup funding from The University of Georgia and funding from the Interdisciplinary Toxicology Program at The University of Georgia). (poster)